Back to top

View the PFP Archive

Stocks closed mostly higher on Friday, with all of the major indexes up for the week.
Kevin Matras   
Profit from the Pros
By Kevin Matras
Executive Vice President
Zacks Investment Research
  

Stocks Up Last Week After Flurry Of Economic News, NVIDIA Earnings On Tap This Week

Stocks closed mostly higher on Friday, with all of the major indexes up for the week.

Big day in terms of news on Friday.

First, the advance estimate for Q4'25 GDP came in at 1.4%, well below Q3's pace of 4.4%, and the consensus for 2.8%. Although, much of that miss was attributed to the record-long (43 days, 10/1 ? 11/12) government shutdown.

Stocks were modestly lower in pre-market activity. And dipped a bit more following the news.

Then came the Personal Consumption Expenditures (PCE) index (for December), and it showed headline inflation up 0.3% m/m vs. last month's 0.2% pace and views for the same. The y/y rate came in at 2.8%, in line with estimates, and up from last month's 2.7%. The core rate (ex-food & energy) was up 0.3% m/m as well vs. last month's 0.2% and forecasts for the same. The y/y rate was at 2.9%, up from last month's 2.8% and expectations for 2.8%.

While it was a bit higher than expected, the reaction was muted.

And then we heard from the Supreme Court on President Trump's use of the IEEPA (International Emergency Economic Powers Act) to impose tariffs. In short, the court said the IEEPA statute does not give the President the authority to impose tariffs. The court did not make a ruling on refunds for the IEEPA-imposed tariffs paid by the plaintiffs.

Stocks turned positive on the news.

It should be noted that the SCOTUS did not exclude any other statutes at the President's disposal to impose tariffs, namely Section 301 (trade retaliation), 232 (national security tariffs), 201 (safeguard tariffs), 122 of the Trade Act of 1974 (balance-of-payment tariffs), and 338 of the Tariff Act of 1930 (discriminatory tariffs).

The President came out later in the day and announced his Administration would impose a "10% global tariff" (under Section 122, which can last for up to 150 days unless Congress acts to extend, and be as high as 15%), "over and above our normal tariffs already being charged." "And we're also initiating several section 301 and other investigations to protect our country from unfair trading practices of other countries and companies."

Stocks firmed up during and after his press conference.

When asked about the potential for issuing refunds, given the court made no mention of that, the President said "I guess it has to get litigated for the next two years."

(Note: on Saturday, President Trump upped the global tariffs to 15%, "effective immediately.")

It was a busy week last week. Between Friday's news, earnings, all of the other reports during the week, not to mention the first week of the new partial government shutdown, and increased tensions with Iran and a possible strike looming, the markets held up exceptionally well.

But that shows the resiliency of the economy, the strength or corporate America, and the U.S. consumer.

We'll get more earnings this week with as many as 1,077 companies in queue to report.

But earnings season 'officially' ends on Wednesday, 2/25, when NVIDIA reports after the close. Another good showing could potentially reset the AI trade, putting it back on the right track and dispelling the notion that AI is in a bubble.

But we'll get plenty of other big name, non-tech companies on deck to report this week as well.

Most of the indexes are within striking distance of their all-time highs.

A little bit of good news could see them breakout to even higher highs in the near offing.

See you tomorrow,

Kevin Matras

Executive Vice President, Zacks Investment Research

Sponsor

Catch Med-X Before Wall Street Does

Med-X is gearing up for a possible Nasdaq listing (ticker: MXRX). But the real opportunity is now – before they hit the big stage.

Their all-natural pesticides have outperformed chemical brands in independent lab tests, providing safer solutions without sacrificing results. Their products are already available through e-commerce giants like Walmart, Amazon, and Kroger, and they plan to expand internationally.

With $6.4M in sales in just four years, they're getting ready for the next step.

Become a Med-X Shareholder Before Their Nasdaq Plans Unfold


Disclosures: This is a paid advertisement for Med-X's Regulation A+ Offering. Please read the offering circular at invest.medx-rx.com

Most Popular Articles from Zacks.com

Image: Bigstock

Nvidia Earnings Loom: A Closer Look at the Mag 7 Earnings Picture

Impressively, Nvidia is on track to bring in almost four times as much in revenue in a single quarter as it did in all of 2021. Read More »

Image: Bigstock

Stocks to Watch as the Supreme Court Rescinds President Trump's Tariffs

Investors will certainly be monitoring the potential tariff relief impact on the global economy, and stocks like APPL, GM and NKE could be poised to benefit. Read More »

Image: Bigstock

The New Magnificent Stocks to Own in 2026

While the Mag 7 maybe over, stocks CAT, WMT, LLY, MTZ and HWM look like worthy replacements. Read More »

Image: Shutterstock

Time to Buy Stock in These Top Asset Managers

Stocks of asset managers tend to be attractive because of their fee-based recurring revenue, scalable business models with high margins, strong cash flow, and shareholder-friendly returns. Read More »

Image: Bigstock

AI, Clean Energy & Health Stocks: The Big Winners in a Multipolar 2026

Amid uneven global growth, AI, clean energy and healthcare lead a polarized 2026 market. Read More »

Sponsor

Why Haven't You Looked at Zacks' Top Stocks?

Since 2000, our top stock-picking strategies have blown away the S&P's +8.1 average gain per year. Amazingly, they soared with average gains of +45.4%, +48.1% and +51.4% per year.

Today you can access their live picks without cost or obligation.

See Stocks Free »

Image: Bigstock

Bull of the Day: Cardinal Health (CAH)

Cardinal Health beat earnings estimates in the trailing four quarters, the average surprise being 9.3%. Read More »

New Zacks Strong Buys for February 23rd

Here are 5 stocks added to the Zacks Rank #1 (Strong Buy) List today. Read More »

 

Download our app for convenient on-the-go access to even more—daily and weekly newsletters published by Zacks experts, proprietary research and tools, and Portfolio Tracker on Zacks.com.

Download our Zacks App for Apple iOS
Download our Zacks App for Android

Visit Success Stories to hear how Zacks research, tools and portfolios help our members outperform the market.